BNTA is a synthetic compound classified as a dopamine D2 receptor agonist, structurally similar to bromocriptine, which is frequently used in research settings to investigate dopaminergic pathways and… Read more









BNTA is a synthetic compound classified as a dopamine D2 receptor agonist, structurally similar to bromocriptine, which is frequently used in research settings to investigate dopaminergic pathways and therapeutic potential for conditions such as Parkinson's disease or hyperprolactinemia. This collection offers high-quality reference standards for BNTA, including identified impurities, potential metabolites, and stable isotope labelled compounds like BNTA-d4. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, method validation, and accurate quantitative analysis. By employing these precise analytical standards, researchers can reliably monitor degradation products and confirm the identity of synthetic by-products during drug development and quality control procedures. These reference materials are essential for maintaining the integrity of experimental data when studying this dopaminergic agent.